Related Experiment Videos

[Epidural stimulation in arteritic patients]

J Herreros1

  • 1Servicio de Cirugia Cardiovascular, Clinica Universitaria de Navarra, Pamplona, Espagne.

Annales De Cardiologie Et D'Angeiologie
|October 1, 1989
PubMed

Insights

Epidural stimulation effectively treats lower extremity arterial diseases, improving blood flow and reducing pain in patients with conditions like arteriosclerosis and Buerger

Area of Science:

  • Vascular Surgery
  • Neuromodulation
  • Peripheral Arterial Disease

Background:

  • Lower extremity arterial diseases present significant challenges, including intractable pain and tissue necrosis.
  • Previous treatments like sympathectomy have variable success rates.
  • Epidural stimulation (ES) offers a potential therapeutic option for these complex conditions.

Purpose of the Study:

  • To evaluate the efficacy of epidural stimulation in treating patients with severe lower extremity arterial diseases.
  • To assess outcomes across various etiologies including arteriosclerosis, diabetic arteriopathy, and specific conditions like Buerger's disease and Raynaud's phenomenon.

Main Methods:

  • A multicenter retrospective study involving 203 patients with Leriche-Fontaine stage III or IV ischemia.
  • Patients received epidural stimulation for indications such as untractable pain or necrosis.
  • Outcomes were assessed based on clinical improvement, plethysmography, transcutaneous PO2, and isotopic perfusion measurements (201TL, 125I antipyrin).

Main Results:

  • Excellent outcomes were observed in 47% of arteriosclerosis/diabetes cases, 100% of Buerger's disease cases, and 78% of Raynaud's disease cases.
  • Good outcomes were achieved in 33% of arteriosclerosis and 12% of Raynaud's disease cases.
  • Statistically significant improvements were noted in plethysmography, transcutaneous PO2, and isotopic perfusion studies.

Conclusions:

  • Epidural stimulation demonstrates significant therapeutic potential for managing severe arterial diseases of the lower extremities.
  • ES offers a viable treatment option for patients with intractable pain and necrosis unresponsive to conventional therapies.
  • The study highlights ES as a promising intervention for improving perfusion and clinical outcomes in peripheral arterial disease.

Related Concept Videos